强化生活方式医学项目在 Medicare 与商业保险肌骨慢性病患者中的比较
回顾性研究比较完成强化生活方式医学项目(ILMP)的 Medicare 与商业保险肌骨患者的基线特征与结局,并比较 Medicare ILMP 患者与常规照护者;Medicare 患者基线慢病负担更重,但服务使用、目标达成与结局相似,且体重下降优于常规照护。
要点
- Medicare 患者基线慢病负担更重,但完成 ILMP 后目标达成与结局与商业保险患者相似。
- Medicare ILMP 患者体重下降 10±14 磅,常规照护组仅 1±4 磅(p<.001)。
- 虚拟跨专业 ILMP 对 Medicare 肌骨慢病患者可行且有效。
核心结论
- 虚拟跨专业 ILMP 对合并生活方式相关慢病的 Medicare 肌骨患者可行且有效,尽管其基线疾病负担高于商业保险患者。
研究设计与样本
- 回顾性探索性研究,分析三级骨科中心 repository 数据;ILMP 组纳入 101 例 Medicare 与 130 例商业保险完成者,另设 90 例 Medicare 常规照护对照。
主要发现
- Medicare ILMP 患者较商业保险 ILMP 患者年龄更大(70±7 vs. 55±10 岁,p<.001),基线≥2 种生活方式相关慢病比例更高(96% vs. 85%;p=.015)。
- Medicare ILMP 患者基线高血压(72% vs. 54%;p=.010)、高脂血症(59% vs. 40%;p=.001)和胃食管反流病(33% vs. 18%;p=.015)比例均高于商业保险 ILMP 患者。
- Medicare 与商业保险 ILMP 患者在项目服务使用、目标达成和结局方面报告相似。
- 与 Medicare 常规照护组相比,Medicare ILMP 组体重下降更多(10±14 磅 vs. 1±4 磅;p<.001)。
临床怎么用
- 对合并生活方式相关慢病的 Medicare 肌骨患者,可考虑转介虚拟跨专业 ILMP 以促进体重管理等结局。
局限性
- 回顾性探索性设计,仅纳入完成项目的患者,完成率 Medicare 50%、商业保险 40%(p=.040),可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Abstract Background Lifestyle medicine (LM) uses evidence-based interventions to reduce chronic systemic inflammation, a driver of chronic diseases and painful musculoskeletal conditions. Medicare beneficiaries represent a high-risk population for chronic systemic inflammation and may benefit from receiving care through an intensive LM program (ILMP). Objective To compare baseline lifestyle factors and outcomes (1) between Medicare and commercially insured patients completing an ILMP, and (2) between Medicare patients completing an ILMP and Medicare patients receiving usual care (non-ILMP). Design Retrospective exploratory study of repository data. Setting Tertiary orthopedic center. Patients A total of 204 Medicare and 322 commercially insured patients entered the ILMP from May 2023 to May 2025; of these, 101 Medicare and 130 commercially insured patients completed the program and were included in this study (50% vs. 40% completion rate; p = .040). A third group of 90 Medicare patients with similar conditions received usual care during this same time frame. Interventions The ILMP virtually integrates individual and group visits with an interprofessional team, with patient-identified health goals. Main Outcome Measures Goal attainment; changes in weight, pain, physical/mental health, and metabolic labs from program enrollment to completion. Results Compared to commercially insured ILMP patients, Medicare ILMP patients were older (70 ± 7 vs. 55 ± 10 years, p < .001) and had higher rates of ≥2 lifestyle-related chronic diseases (96% vs. 85%; p = .015), hypertension (72% vs. 54%; p = .010), hyperlipidemia (59% vs. 40%; p = .001), and gastroesophageal reflux disease (33% vs. 18%; p = .015) at baseline. Medicare and commercially insured ILMP patients reported similar use of program services, goal attainment, and outcomes. Compared to the Medicare usual-care group, the Medicare ILMP group had similar baseline characteristics but achieved greater weight loss (10 ± 14 lbs vs. 1 ± 4 lbs; p < .001). Conclusions An interprofessional ILMP delivered virtually is feasible and effective for Medicare patients with musculoskeletal conditions and lifestyle-related chronic diseases, despite having a greater baseline disease burden compared with commercially insured patients.
引用
- PM&R:Comparative lifestyle factors and outcomes of an intensive interprofessional lifestyle medicine program versus usual care in Medicare and commercially insured musculoskeletal patients with chronic disease
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。